Vasalgel

20/07/2022

Announced today: NEXT Life Sciences will lead the final steps in the development of Vasalgel male contraceptive, including clinical trials and regulatory review.

The Parsemus Foundation and Revolution Contraceptives announce that NEXT Life Sciences has been selected to develop Vasalgel male contraceptive.

22/05/2022

Men: have you had a ? Share your thoughts and experiences through a 10-15 minute online survey! https://bit.ly/3Fxj9mh

20/04/2022

Men ages 18-50 who have had a female sexual partner: take this anonymous survey and you’ll be invited to submit your contact info to be entered in a raffle for a $20 gift certificate.

You're invited to participate in a research study about men’s views on gender roles. The study consists of an online survey that will take about 10 minutes to complete.

28/01/2022

The Male Contraceptive Initiative’s Youth Advisory Board recently selected four undergraduate students for awards to fund research in male contraception. The Parsemus Foundation is proud to support these awards to encourage more young scholars to pursue studies in improving reproductive health. The 2021-22 awardees are: Malena Gabri (Universidad de Buenos Aires), Kenitimi Bikikoro (Niger Delta University, Wilberforce Island.), Aryani Pallerla (The University of North Carolina at Chapel Hill), and Madeline Mahoney (The University of Chicago).

The Male Contraceptive Initiative’s Youth Advisory Board recently selected four undergraduate students for awards to fund research in male contraception. The Parsemus Foundation is proud to support these awards to encourage more young scholars to pursue studies in improving reproductive health. Th...

23/01/2022

Do you know a graduate student or young professionals who may be interested in contraceptive R&D as a possible career path? Or perhaps that description fits you? The Contraceptive Technology Innovation Exchange invites you to apply for its "Emerging Leaders in Contraceptive Technology Innovation" mentorship program.

Anuncio en Español Annonce en Français This year, the Contraceptive Technology Innovation (CTI) Exchange is launching a virtual mentorship program called Emerging Leaders in Contraceptive Technology Innovation. If you are a graduate student or you professional (within 5 years of finishing graduate...

09/08/2021

The Male Contraceptive Initiative announced that the Youth Advisory Board Undergraduate Project Grant program is accepting applications until September 30, 2021. The grant aims to support students interested in research or advocacy related to male contraception, with funding in the range of $500-100...

24/07/2021

A raíz de algunos informes de prensa inexactos, hemos estado recibiendo muchas consultas desde México. Los medios de comunicación tomaron noticias viejas y las mezclaron, ¡pero se extendieron rápidamente!

A pesar de lo que los artículos dicen, Vasalgel aún no está disponible para el público en ninguna parte (y, en realidad, tampoco lo está RISUG). No podemos predecir cuándo Vasalgel estará disponible en el mercado, pero no será este año, y probablemente falten algunos años más.

¿Se pregunta cómo están las cosas REALMENTE? Toda la información que nosotros tenemos públicamente disponible está en línea en https://www.revolutioncontraceptives.com/.

Cuando tenemos noticias, siempre las compartimos en Facebook, Twitter (https://twitter.com/Vasalgel), nuestro blog (https://www.revolutioncontraceptives.com/news/vasalgel-blog/) y por correo electrónico. Únase a nuestra lista de correo electrónico en http://eepurl.com/dn5s7L.

Revolution Contraceptives Email Forms

11/06/2020

Congratulations to the Male Contraceptive Initiative for the launch of "Intended," a new podcast that explores the past, present, and future of .

Intended is a new podcast from Male Contraceptive Initiative that asks the question - Why have we been 10 years away from the Male Pill for 50 years?

03/12/2019

More than 85,000,000 unintended pregnancies happen around the world each year; half end in abortion. Men who aren’t relying on their female partners for contraception have few choices: condoms, vasectomy, withdrawal, or abstinence. We're developing a new option: Vasalgel.

Our mission is to provide men with the first effective, long-term, and reversible option to control their fertility.

, December 3, is the global day of giving. We hope you share our belief that Vasalgel will benefit millions of people worldwide.

Please donate to support the development of Vasalgel. Thank you.

Fill out my LGL form!